Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Royalty Pharma Stock: The Quiet Compounder The Market Is Still Mispricing (NASDAQ:RPRX)
Royalty Pharma demonstrates high-quality, cash-generative compounding with durable royalty growth and disciplined capital deployment, supporting a buy rating. RPRX's 2Q26 results highlight 14% Royalty Receipts growth, elite 95% margins, and $728…
Nxera Pharma's Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition
NBI-1117567 is an investigational oral, muscarinic M1 preferring (M1/M4) selective agonist discovered by Nxera and advancing through clinical development under a multi-program collaboration with Neurocrine Nxera to receive a US$10 million milestone…
Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus
The Fidelity MSCI Health Care Index ETF (FHLC +0.47%) provides broad, low-cost exposure to the entire healthcare sector, whereas the VanEck Pharmaceutical ETF (PPH +1.19%) offers a concentrated, higher-yielding focus on global pharmaceutical…
Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations
Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company's SBTi-approved decarbonisation journey Mumbai, India, Aug. 26, 2026 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals…
Odyssean LLC Acquires 21,401 Shares of Royalty Pharma PLC $RPRX
Odyssean LLC grew its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 65.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional…
ADWEEK Ramps Up Healthcare Marketing Coverage
The future of brands gets decided here. Join the industry's top marketers at Brandweek for the ideas, insights, and connections shaping what's next. Get your ticket. Health is top-of-mind for nearly everyone these days. Whether you're rethinking…
In ten months, Japan invested Rs 1 lakh cr out of Rs 7 lakh cr targeted for 10 yrs: Goyal
3 min read New Delhi, Tokyo Make us preferred source on Google Union Commerce Minister Piyush Goyal on Wednesday said that Japan is one of India's most strategic partners and India is working to expand the scope, scale and extent of the engagement.
Agilent forecasts FY2026 revenue of $7.49B-$7.51B and EPS of $6.18-$6.21 as China returns to 9% growth (NYSE:A)
Earnings Call Insights: Agilent Technologies (A) Q3 2026 'We delivered an excellent third quarter with strong performance on both the top and bottom lines.' (CEO, President & Director Padraig McDonnell) 'For the third quarter, Agilent reported…
/afaqs/media/media_library/vi/AR4jM8vhg70/hqdefault-972320.jpg)
Lacto Calamine deepens its oily-skin expertise with strategic launch of light gel moisturization range
Piramal Pharma Limited's India Consumer Healthcare (PCH) business with its brand Lacto Calamine is venturing into light gel moisturizers. Building on its longstanding expertise in oily skincare, Lacto Calamine has launched a new range of light gel…
Woodside Energy: The $5 Billion Reset Helps, But I'm Not Buying Yet (NYSE:WDS)
Woodside Energy delivered solid H1 results, but valuation already reflects Scarborough's imminent cash flow and improved capital discipline. WDS shifts to a unified capital allocation framework, abandoning its $5B new-energy spending target and…
Senegal-made sickle cell treatment raises hopes, reduces costs
Senegalese laboratory pioneers affordable drug production, introducing generic hydroxyurea, the first of its kind in Africa and the gold standard for treating sickle cell disease. Mamadou Tahirou is 18 but looks more like a 12-year-old, his frame…
Vuelta a España: Matthew Brennan sprints to second win on stage 5 as late climb fails to drop sprinter
Matthew Brennan (Visma-Lease a Bike) sped to his second victory of the Vuelta a España on stage 5, outpacing Jordi Meeus (Red Bull-Bora-Hansgrohe) to the finish line in a reduced bunch sprint in Roquetas. Visma-Lease a Bike's control at the…
Update on the Tamiflu scandal, as the media continues to sit on the study showing the drug killed the flu patients it was prescribed to help
Yesterday, I wrote about a stunning study showing the flu drug Tamiflu (oseltamivir) is deadly to critically ill influenza patients. I think - I hope, anyway - that big legacy media outlets will eventually have to follow the news, even if they'd…
My 2 Favorite Dividend Stocks to Buy in August
When a raging bull market eventually loses momentum, investors generally rotate into stable, income-generating stocks. When most stocks look expensive, dividend stocks can be reliable income payors that send you checks regularly. However, investing…
Agilent Technologies Q3 Earnings Call Highlights
Alcoa's Gallium Project Opens a New Door Beyond Aluminum Agilent Technologies NYSE: A reported third-quarter fiscal 2026 revenue of $1.88 billion, with core revenue growth of 7.3%, exceeding the high end of its guidance range. The company said…
Receive a Daily briefing on Pharma Industry News
Get Started